U.S., Dec. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07306130) titled 'Consensus on Skin Care in Breast Cancer Patients' on Dec. 06.
Brief Summary: Skin toxicity is one of the most common and impactful adverse effects of breast cancer treatment, affecting patients undergoing chemotherapy, targeted therapies, endocrine therapy, and radiotherapy. Current research and expert consensus highlight the importance of early, preventive, and gentle skin-care regimens to preserve barrier function and reduce treatment interruptions. Evidence supports the use of mild, fragrance-free cleansers, twice-daily emollient moisturization, and consistent broad-spectrum photoprotection throughout therapy. For radiation derma...